Toleranzia AB (OSTO:TOL) Accounts Payable & Accrued Expense : kr3.29 Mil (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Toleranzia AB Accounts Payable & Accrued Expense?

Toleranzia AB's quarterly accounts payable & accrued expense declined from Sep. 2024 (kr8.43 Mil) to Dec. 2024 (kr4.29 Mil) and declined from Dec. 2024 (kr4.29 Mil) to Mar. 2025 (kr3.29 Mil).

Toleranzia AB's annual accounts payable & accrued expense increased from Dec. 2022 (kr3.96 Mil) to Dec. 2023 (kr4.56 Mil) but then declined from Dec. 2023 (kr4.56 Mil) to Dec. 2024 (kr4.29 Mil).

Toleranzia AB Accounts Payable & Accrued Expense Historical Data

The historical data trend for Toleranzia AB's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Toleranzia AB Accounts Payable & Accrued Expense Chart

Toleranzia AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1.78

2.38

3.96

4.56

4.29

Toleranzia AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1.54	2.84	8.43	4.29	3.29

Toleranzia AB Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Toleranzia AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Toleranzia AB (OSTO:TOL) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

Arvid Wallgrens backe 20, 8th floor, Gothenburg, SWE, 413 46

Website

https://www.toleranzia.com

Toleranzia AB is a Swedish biotechnology company. It develops drugs that harness the power of the immune system to treat autoimmune orphan diseases. The company uses its tolerance technology for drug development, which is based on the identification of disease-specific proteins that are developed into biological drugs, specific to each autoimmune disease. Its drug development pipeline includes TOL2, which is being developed for the treatment of autoimmune orphan disease myasthenia gravis, and TOL3, being developed for another indication in autoimmune orphan diseases, ANCA vasculitis.